SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Pappas Ventures Names Eric Linsley Managing Partner
News | 09. 28. 2009
Pappas Ventures today announced that Eric W. Linsley has been promoted to Managing Partner.
